Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase I Trial of Re-Irradiation With Concurrent Chemotherapy in Combination With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Squamous Cell Carcinoma

The purpose of this study is to evaluate the safety, tolerability and maximum tolerated dose of tislelizumab in combination with pamiparib plus chemoradiothera…

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+2 more

University of ChicagoNCT05526924